Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$1.76 - $2.83 $440 - $707
-250 Reduced 0.25%
100,250 $254,000
Q2 2023

Aug 10, 2023

BUY
$2.1 - $3.36 $1,050 - $1,680
500 Added 0.5%
100,500 $232,000
Q1 2023

May 11, 2023

SELL
$2.13 - $3.6 $53,250 - $90,000
-25,000 Reduced 20.0%
100,000 $255,000
Q4 2022

Feb 07, 2023

BUY
$2.05 - $3.47 $92,249 - $156,150
45,000 Added 56.25%
125,000 $313,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $18,900 - $164,100
30,000 Added 60.0%
80,000 $232,000
Q2 2022

Jul 19, 2022

BUY
$4.27 - $8.26 $21,349 - $41,300
5,000 Added 11.11%
50,000 $226,000
Q1 2022

May 04, 2022

BUY
$7.07 - $11.62 $63,630 - $104,580
9,000 Added 25.0%
45,000 $360,000
Q4 2021

Jan 31, 2022

BUY
$10.49 - $14.28 $167,840 - $228,480
16,000 Added 80.0%
36,000 $419,000
Q3 2021

Oct 29, 2021

BUY
$9.94 - $12.77 $198,800 - $255,400
20,000 New
20,000 $247,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.